最近发展的素装载纳米载体在准癌症的目标
Biswakanth Kar1, Sudhanshu Ranjan Rout1, Jitu Halder1
1Department of Pharmaceutics, School of Pharmaceutical Sciences, Siksha 'O' Anusandhan (Deemed to be University), Bhubaneswar, Odisha, 751003, India.
Current pharmaceutical design
|July 4, 2024
概括
纳米配方增强氨酸 (LUT) 溶解性和癌症治疗的生物可用性. 这些纳米载体还可以减少化疗的副作用,改善患者的治疗结果.
科学领域:
- 药理学 药理学是指药理学的学科.
- 纳米技术 纳米技术
- 在瘤学瘤学.
背景情况:
- 素 (LUT) 是一种天然的黄类化合物,具有抗癌和抗氧化特性.
- 较差的水溶性和较低的生物可用性限制了LUT的治疗用途.
- 开发含有黄素的纳米载体旨在克服癌症治疗的这些局限性.
研究的目的:
- 审查纳米配方,以提高氨酸 (LUT) 溶解度和生物可用性.
- 为了研究LUT的特性如何减轻化疗副作用.
- 探索纳米LUTE在癌症治疗中的潜力.
主要方法:
- 对各种纳米配方 (植物体,脂质纳米颗粒,脂质体等) 的审查. ) 的情况.
- 对影响LUT溶解性和生物利用性的物理化学性质的分析.
- 在癌症治疗环境中检查LUT的抗炎和抗氧化作用.
主要成果:
- 多个纳米配方显著改善了LUT的溶解性和生物可用性.
- LUT的自由基清除能力减少了化疗的副作用.
- 纳米配方在增强LUT在瘤学中的治疗潜力方面表现有前途.
结论:
- 纳米配方由于独特的特性而提高了LUT的溶解性和生物可用性.
- 需要对体外/体外相关性和可扩展性进行进一步的研究,以便在临床瘤学中使用.
- 优化纳米-LUTE传递有望改善癌症治疗结果.
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:39lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K